HPV

Papilocare 21 Cannulas This 21 Cannula product variation is intended for a woman's first month of Papilocare application. Who can use Papilocare? The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL). What is Papilocare and how does it work? Papilocare is the first clinically proven treatment solution for HPV-induced low grade (ASCUS, LSIL, CIN 1) lesions of the cervical transformation zone. The Coriolus versicolor-based vaginal gel is specifically formulated to activate the three modifiable HPV-induced low grade lesion repair factors. 1. Re-epithelialisation of the cervical transformation zone 2. Rebalancing the vaginal microbiota 3. Counteracting the non-inflammatory microenvironment that HPV creates.

Papilocare 77 Cannulas This 77 Cannula product variation is intended for a woman's full 6 month Papilocare application. Who can use Papilocare? The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL). What is Papilocare and how does it work? Papilocare is the first clinically proven treatment solution for HPV-induced low grade (ASCUS, LSIL, CIN 1) lesions of the cervical transformation zone. The Coriolus versicolor-based vaginal gel is specifically formulated to activate the three modifiable HPV-induced low grade lesion repair factors. 1. Re-epithelialisation of the cervical transformation zone 2. Rebalancing the vaginal microbiota 3. Counteracting the non-inflammatory microenvironment that HPV creates.